S-Space

Browse

Subject

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 40 of 75

Issue Date	Title / Author(s) / Citation	File
1997-02	Establishment and characterization of human gastric carcinoma cell lines Park, Jae‐Gahb; Yang, Han‐Kwang; Kim, Woo Ho; Chung, June‐Key; Kang, Myung‐Soo; Lee, Jae‐Ho; Oh, Jae Hwan; Park, Hyun‐Sook; Yeo, Kyong‐Sook; Kang, Shin Hyuck; Song, Sang‐Yong; Kang, Yun Kyung; Bang, Yung-Jue; Kim, Yong Il; Kim, Jin‐Pok International Journal of Cancer, Vol.70 No.4, pp.443-449	DOI
1998-08	Genetic integrity of transforming growth factor beta (TGF-beta) receptors in cervical carcinoma cell lines: Loss of growth sensitivity but conserved transcriptional response to TGF-beta Kang, Shin H.; Won, Kyungshick; Chung, Hwan‐Wook; Jong, Hyun‐Soon; Song, Yong‐Sang; Kim, Seong‐Jin; Bang, Yung‐Jue; Kim, Noe K. International Journal of Cancer, Vol.77 No.4, pp.620-625	DOI
1999-04	Truncation of the TGF-β type II receptor gene results in insensitivity to TGF-β in human gastric cancer cells Yang, Han-Kwang; Kang, Shin Hyeok; Kim, Yong-Seok; Won, Kyungshick; Bang, Yung-Jue; Kim, Seong-Jin Oncogene, Vol.18 No.13, pp.2213-2219	DOI
2000-07	Methylation of specific CpG sites in the promoter region could significantly down-regulate p16(INK4a) expression in gastric adenocarcinoma Song, Sang Hyun; Jong, Hyun‐Soon; Choi, Hyun Ho; Kang, Shin Hyeok; Ryu, Min Hee; Kim, Noe Kyeong; Kim, Woo‐Ho; Bang, Yung‐Jue International Journal of Cancer, Vol.87 No.2, pp.236-240	DOI
2003-10	A novel ginseng saponin metabolite induces apoptosis and down-regulates fibroblast growth factor receptor 3 in myeloma cells Choi, Hyun Ho; Jong, Hyun-Soon; Park, Jung-Hyun; Choi, Seongwon; Lee, Jung Weon; Kim, Tae-You; Otsuki, Takemi; Namba, Masayoshi; Bang, Yung-Jue International Journal of Oncology, Vol.23 No.4, pp.1087-1093	DOI
2004-03	Phylogenetic analysis of the genera Streptomyces and Kitasatospora based on partial RNA polymerase β-subunit gene (rpoB) sequences Kim, Bum-Joon; Kim, Chang-Jin; Chun, Jongsik; Koh, Young-Hwan; Lee, Sueng-Hyun; Hyun, Jin-Won; Cha, Chang-Yong; Kook, Yoon-Hoh International Journal of Systematic and Evolutionary Microbiology, Vol.54 No.2, pp.593-598	DOI
2008-07	Mucoepidermoid carcinoma of lung: Potential target of EGFR-directed treatment Han, Sae-Won; Kim, Hwang-Phill; Jeon, Yoon Kyung; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Chung, Doo Hyun; Heo, Dae Seog; Bang, Yung-Jue; Kim, Tae-You Lung Cancer, Vol.61 No.1, pp.30-34	DOI
2009-08	Class III beta-tubulin, but not ERCC1, is a strong predictive and prognostic marker in locally advanced head and neck squamous cell carcinoma Koh, Y.; Kim, T. M.; Jeon, Y. K.; Kwon, T. -K.; Hah, J. H.; Lee, S. -H.; Kim, D. -W.; Wu, H. -G.; Rhee, C. -S.; Sung, M. -W.; Kim, C. W.; Kim, K. H.; Heo, D. S. Annals of Oncology, Vol.20 No.8, pp.1414-1419	DOI
2009-09	Combination of EGFR and MEK1/2 inhibitor shows synergistic effects by suppressing EGFR/HER3-dependent AKT activation in human gastric cancer cells Yoon, Young-Kwang; Kim, Hwang-Phill; Han, Sae-Won; Hur, Hyung-Seok; Oh, Do Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You Molecular Cancer Therapeutics, Vol.8 No.9, pp.2526-2536	DOI
2009-11	Differences in the Expression Profiles of Excision Repair Crosscomplementation Group 1, X-Ray Repair Crosscomplementation Group 1, and beta III-Tubulin Between Primary Non-small Cell Lung Cancer and Metastatic Lymph Nodes and the Significance in Mid-Term Survival Kang, Chang Hyun; Jang, Bo Gun; Kim, Dong-Wan; Chung, Doo Hyun; Kim, Young Tae; Jheon, Sanghoon; Sung, Sook-Whan; Kim, Joo Hyun Journal of Thoracic Oncology, Vol.4 No.11, pp.1307-1312	DOI
2010-03	Epidermal growth factor receptor intron 1 CA dinucleotide repeat polymorphism and survival of advanced gastric cancer patients treated with cetuximab plus modified FOLFOX6 Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Park, Sook Ryun; Lee, Keun-Wook; Song, Hong Suk; Lee, Nam-Su; Lee, Kyung Hee; Choi, In Sil; Lee, Moon Hee; Kim, Min A.; Kim, Woo Ho; Bang, Yung-Jue; Kim, Tae-You Cancer Science, Vol.101 No.3, pp.793-799	DOI
2010-04	KRAS Mutant Lung Cancer Cells Are Differentially Responsive to MEK Inhibitor Due to AKT or STAT3 Activation: Implication for Combinatorial Approach Yoon, Young-Kwang; Kim, Hwang-Phill; Han, Sae-Won; Oh, Do Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You Molecular Carcinogenesis, Vol.49 No.4, pp.353-362	DOI
2011-03	Screening of anaplastic lymphoma kinase rearrangement by immunohistochemistry in non-small cell lung cancer: Correlation with fluorescence in situ hybridization Paik, Jin Ho; Choe, Gheeyoung; Kim, Hyojin; Choe, Ji-Young; Lee, Hyun Ju; Lee, Choon-Taek; Lee, Jong Seok; Jheon, Sanghoon; Chung, Jin-Haeng Journal of Thoracic Oncology, Vol.6 No.3, pp.466-472	DOI
2011-04	EGFR Gene Copy Number Gain is Related to High Tumor SUV and Frequent Relapse after Adjuvant Chemotherapy in Resected Lung Adenocarcinoma Koh, Youngil; Jang, Bogun; Jeon, Yoon Kyung; Kim, Tae Min; Lee, Se-Hoon; Kim, Dong-Wan; Chung, Doo Hyun; Kim, Young Tae; Kim, Young Whan; Heo, Dae Seog Japanese Journal of Clinical Oncology, Vol.41 No.4, pp.548-554	DOI
2011-05	Clinicopathologic Characteristics and Outcomes of Patients with Anaplastic Lymphoma Kinase-Positive Advanced Pulmonary Adenocarcinoma Suggestion for an Effective Screening Strategy for These Tumors Koh, Youngil; Kim, Dong-Wan; Kim, Tae Min; Lee, Se-Hoon; Jeon, Yoon Kyung; Chung, Doo Hyun; Kim, Young-Whan; Heo, Dae Seog; Kim, Woo-Ho; Bang, Yung-Jue Journal of Thoracic Oncology, Vol.6 No.5, pp.905-912	DOI
2011-05	Activity of Crizotinib (PF02341066), a Dual Mesenchymal-Epithelial Transition (MET) and Anaplastic Lymphoma Kinase (ALK) Inhibitor, in a Non-small Cell Lung Cancer Patient with De Novo MET Amplification Ou, Sai-Hong Ignatius; Kwak, Eunice L.; Siwak-Tapp, Christina; Dy, Joni; Bergethon, Kristin; Clark, Jeffrey W.; Camidge, D. Ross; Solomon, Benjamin J.; Maki, Robert G.; Bang, Yung-Jue; Kim, Dong-Wan; Christensen, James; Tan, Weiwei; Wilner, Keith D.; Salgia, Ravi; Iafrate, A. John Journal of Thoracic Oncology, Vol.6 No.5, pp.942-946	DOI
2012-06	Clinicopathologic implication of ALK rearrangement in surgically resected lung cancer A proposal of diagnostic algorithm for ALK-rearranged adenocarcinoma Paik, Jin Ho; Choi, Chang-Min; Kim, Hyojin; Jang, Se Jin; Choe, Gheeyoung; Kim, Dong Kwan; Kim, Hwa Jung; Yoon, Hoil; Lee, Choon-Taek; Jheon, Sanghoon; Choe, Ji-Young; Chung, Jin-Haeng Lung Cancer, Vol.76 No.3, pp.403-409	DOI
2012-06	Remarkable Tumor Response to Crizotinib in a 14-Year-Old Girl With ALK-Positive Non-Small-Cell Lung Cancer Kim, Su-Jung; Kim, Dong-Wan; Kim, Tae Min; Lee, Se-Hoon; Heo, Dae Seog; Bang, Yung-Jue Journal of Clinical Oncology, Vol.30 No.16, pp.E147-E150	DOI
2012-07	Comparative analyses of overall survival in patients with anaplastic lymphoma kinase-positive and matched wild-type advanced nonsmall cell lung cancer Lee, June Koo; Park, Heae Surng; Kim, Dong-Wan; Kulig, Kimary; Kim, Tae Min; Lee, Se-Hoon; Jeon, Yoon-Kyung; Chung, Doo Hyun; Heo, Dae Seog; Kim, Woo-Ho; Bang, Yung-Jue Cancer, Vol.118 No.14, pp.3579-3586	DOI
2012-07	MET in gastric carcinomas: comparison between protein expression and gene copy number and impact on clinical outcome Lee, H. E.; Kim, M. A.; Lee, H. S.; Jung, E-J; Yang, H-K; Lee, B. L.; Bang, Y-J; Kim, W. H. British Journal of Cancer, Vol.107 No.2, pp.325-333	DOI
2012-08	Immunohistochemical screening for anaplastic lymphoma kinase (ALK) rearrangement in advanced non-small cell lung cancer patients Park, Heae Surng; Lee, June Koo; Kim, Dong-Wan; Kulig, Kimary; Kim, Tae Min; Lee, Se-Hoon; Jeon, Yoon-Kyung; Chung, Doo Hyun; Heo, Dae Seog Lung Cancer, Vol.77 No.2, pp.288-292	DOI
2012-10	Treatment of ALK-Positive Non-Small Cell Lung Cancer Bang, Yung-Jue Archives of Pathology and Laboratory Medicine, Vol.136 No.10, pp.1201-1204	DOI
2013-01	Discordance between anaplastic lymphoma kinase status in primary non-small-cell lung cancers and their corresponding metastases Kim, Hyojin; Xu, Xianhua; Yoo, Seol-Bong; Sun, Ping-Li; Jin, Yan; Paik, Jin Ho; Choe, Gheeyoung; Jheon, Sanghoon; Lee, Choon-Taek; Chung, Jin-Haeng Histopathology, Vol.62 No.2, pp.305-314	DOI
2013-03	Metabolic and metastatic characteristics of ALK-rearranged lung adenocarcinoma on FDG PET/CT Choi, Hongyoon; Paeng, Jin Chul; Kim, Dong-Wan; Lee, June Koo; Park, Chang Min; Kang, Keon Wook; Chung, June-Key; Lee, Dong Soo Lung Cancer, Vol.79 No.3, pp.242-247	DOI
2013-05	Targeted Sequencing of Cancer-Related Genes in Colorectal Cancer Using Next-Generation Sequencing Han, Sae-Won; Kim, Hwang-Phill; Shin, Jong-Yeon; Jeong, Eun-Goo; Lee, Won-Chul; Lee, Kyung-Hun; Won, Jae-Kyung; Kim, Tae-Yong; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Jeong, Seung-Yong; Park, Kyu Joo; Park, Jae-Gahb; Kang, Gyeong Hoon; Seo, Jeong-Sun; Kim, Jong-Il; Kim, Tae-You PLoS ONE, Vol.8 No.5, p. e64271	DOI
2013-06	Differing effects of adjuvant chemotherapy according to BRCA1 nuclear expression in gastric cancer Kim, Jin Won; Cho, Hyun Jin; Kim, Miso; Lee, Kyung-Hun; Kim, Min A.; Han, Sae-Won; Oh, Do-Youn; Lee, Hyuk-Joon; Im, Seock-Ah; Kim, Tae-You; Yang, Han-Kwang; Kim, Woo Ho; Bang, Yung-Jue Cancer Chemotherapy and Pharmacology, Vol.71 No.6, pp.1435-1443	DOI
2013-06	Norrin expression in endothelial cells in the developing mouse retina Lee, Hanjae; Jo, Dong Hyun; Kim, Jin Hyoung; Kim, Jeong Hun Acta Histochemica, Vol.115 No.5, pp.447-451	DOI
2013-11	Clinicopathologic Analysis of ROS1-Rearranged Non-Small-Cell Lung Cancer and Proposal of a Diagnostic Algorithm Go, Heounjeong; Kim, Dong-Wan; Kim, Donghyun; Keam, Bhumsuk; Kim, Tae Min; Lee, Se-Hoon; Heo, Dae Seog; Bang, Yung-Jue; Chung, Doo Hyun Journal of Thoracic Oncology, Vol.8 No.11, pp.1445-1450	DOI
2013-12	Establishment and characterization of seven human breast cancer cell lines including two triple-negative cell lines Ku, Ja-Lok; Park, Sung-Chan; Kim, Kyung-Hee; Jeon, You-Kyung; Kim, Sung-Hee; Shin, Young-Kyoung; Noh, Dong-Young; Im, Seock-Ah; Bang, Yung-Jue; Han, Wonshik; Kim, Woo Ho; Park, Jae-Gahb International Journal of Oncology, Vol.43 No.6, pp.2073-2081	DOI
2014-01	Ataxia-telangiectasia-mutated protein expression with microsatellite instability in gastric cancer as prognostic marker Kim, Jin Won; Im, Seock-Ah; Kim, Min A.; Cho, Hyun Jin; Lee, Dae Won; Lee, Kyung-Hun; Kim, Tae-Yong; Han, Sae-Won; Oh, Do-Youn; Lee, Hyuk-Joon; Kim, Tae-You; Yang, Han-Kwang; Kim, Woo Ho; Bang, Yung-Jue International Journal of Cancer, Vol.134 No.1, pp.72-80	DOI
2014-02	Clinical benefit of continuing ALK inhibition with crizotinib beyond initial disease progression in patients with advanced ALK-positive NSCLC Ou, Sai-Hong I.; Jaenne, P. A.; Bartlett, C. H.; Tang, Y.; Kim, D. -W.; Otterson, G. A.; Crino, L.; Selaru, P.; Cohen, D. P.; Clark, J. W.; Riely, G. J. Annals of Oncology, Vol.25 No.2, pp.415-422	DOI
2014-04	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors vs Conventional Chemotherapy in Non-Small Cell Lung Cancer Harboring Wild-Type Epidermal Growth Factor Receptor A Meta-analysis Lee, June-Koo; Hahn, Seokyung; Kim, Dong-Wan; Suh, Koung Jin; Keam, Bhumsuk; Kim, Tae Min; Lee, Se-Hoon; Heo, Dae Seog JAMA - Journal of the American Medical Association, Vol.311 No.14, pp.1430-1437	DOI
2014-08	ALK Molecular Phenotype in Non-Small Cell Lung Cancer: CT Radiogenomic Characterization Yamamoto, Shota; Korn, Ronald L.; Oklu, Rahmi; Migdal, Christopher; Gotway, Michael B.; Weiss, Glen J.; Iafrate, A. John; Kim, Dong-Wan; Kuo, Michael D. Radiology, Vol.272 No.2, pp.568-576	DOI
2014-10	Nomogram Predicting Clinical Outcomes in Non-small Cell Lung Cancer Patients Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Keam, Bhumsuk; Kim, Dong-Wan; Park, Jin Hyun; Lee, Jeong-Ok; Kim, Tae Min; Lee, Se-Hoon; Chung, Doo Hyun; Heo, Dae Seog Cancer Research and Treatment, Vol.46 No.4, pp.323-330	DOI
2014-11	STAT3 inhibition suppresses proliferation of retinoblastoma through down-regulation of positive feedback loop of STAT3/miR-17-92 clusters Jo, Dong Hyun; Kim, Jin Hyoung; Cho, Chang Sik; Cho, Young-Lai; Jun, Hyoung Oh; Yu, Young Suk; Min, Jeong-Ki; Kim, Jeong Hun Oncotarget, Vol.5 No.22, pp.11513-11525	DOI
2014-12	The gefitinib dose reduction on survival outcomes in epidermal growth factor receptor mutant non-small cell lung cancer Sim, Sung Hoon; Keam, Bhumsuk; Kim, Dong-Wan; Kim, Tae Min; Lee, Se-Hoon; Chung, Doo Hyun; Heo, Dae Seog Journal of Cancer Research and Clinical Oncology, Vol.140 No.12, pp.2135-2142	DOI
2015-04	AZD9291 in EGFR inhibitor-resistant non-small-cell lung cancer Jaenne, Pasi A.; Yang, James Chih-Hsin; Kim, Dong-Wan; Planchard, David; Ohe, Yuichiro; Ramalingam, Suresh S.; Ahn, Myung-Ju; Kim, Sang-We; Su, Wu-Chou; Horn, Leora; Haggstrom, Daniel; Felip, Enriqueta; Kim, Joo-Hang; Frewer, Paul; Cantarini, Mireille; Brown, Kathryn H.; Dickinson, Paul A.; Ghiorghiu, Serban; Ranson, Malcolm New England Journal of Medicine, Vol.372 No.18, pp.1689-1699	DOI
2015-05	A randomized phase II study of the MEK1/MEK2 inhibitor trametinib (GSK1120212) compared with docetaxel in KRAS-mutant advanced non-small-cell lung cancer (NSCLC) Blumenschein, G. R., Jr.; Smit, E. F.; Planchard, D.; Kim, D. -W.; Cadranel, J.; De Pas, T.; Dunphy, F.; Udud, K.; Ahn, M. -J.; Hanna, N. H.; Kim, J. -H.; Mazieres, J.; Kim, S. -W.; Baas, P.; Rappold, E.; Redhu, S.; Puski, A.; Wu, F. S.; Jaenne, P. A. Annals of Oncology, Vol.26 No.5, pp.894-901	DOI
2016-03	EML4-ALK enhances programmed cell death-ligand 1 expression in pulmonary adenocarcinoma via hypoxia-inducible factor (HIF)-1 alpha and STAT3 Koh, Jaemoon; Jang, Ji-Young; Keam, Bhumsuk; Kim, Sehui; Kim, Moon-Young; Go, Heounjeong; Kim, Tae Min; Kim, Dong-Wan; Kim, Chul-Woo; Jeon, Yoon Kyung; Chung, Doo Hyun OncoImmunology, Vol.5 No.3, p. e1108514	DOI
2016-04	Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial Cristofanilli, Massimo; Turner, Nicholas C.; Bondarenko, Igor; Ro, Jungsil; Im, Seock-Ah; Masuda, Norikazu; Colleoni, Marco; DeMichele, Angela; Loi, Sherene; Verma, Sunil; Iwata, Hiroji; Harbeck, Nadia; Zhang, Ke; Theall, Kathy Puyana; Jiang, Yuqiu; Bartlett, Cynthia Huang; Koehler, Maria; Slamon, Dennis The Lancet Oncology, Vol.17 No.4, pp.425-439	DOI

1 2